Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61,769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Ding Y, Mo W, Xie X, Wang O, He X, Zhao S, Gu X, Liang C, Qin C, Ding K, Yang H, Ding X. Ding Y, et al. Among authors: yang h. Oncol Res Treat. 2023;46(7-8):303-311. doi: 10.1159/000531492. Epub 2023 Jun 9. Oncol Res Treat. 2023. PMID: 37302393 Clinical Trial.
Longitudinal Trajectories of Asthma and Allergic Comorbidities in the Korean Childhood Asthma Study.
Yoon J, Yang HJ, Rhee EH, Lee E, Park JS, Jung S, Kim K, Kim HS, Baek HS, Kim WK, Yoo Y, Suh DI, Shin M, Kwon JW, Jang GC, Seo JH, Woo SI, Kim HY, Shin YH, Lee JS, Kim JT, Lim DH, Lee SW, Song DJ, Yu J. Yoon J, et al. Among authors: yang hj. Allergy Asthma Immunol Res. 2025 Jan;17(1):47-59. doi: 10.4168/aair.2025.17.1.47. Allergy Asthma Immunol Res. 2025. PMID: 39895602
61,769 results
You have reached the last available page of results. Please see the User Guide for more information.